ArticleHepatology communications2024

Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.

Paul R Burchard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.